These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6524363)

  • 1. Pulse methylprednisolone therapy in severe idiopathic childhood nephrotic syndrome.
    Murnaghan K; Vasmant D; Bensman A
    Acta Paediatr Scand; 1984 Nov; 73(6):733-9. PubMed ID: 6524363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
    Fukudome K; Fujimoto S; Sato Y; Kitamura K
    Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
    Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
    Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of childhood nephrotic syndrome.
    Mendoza SA; Tune BM
    J Am Soc Nephrol; 1992 Oct; 3(4):889-94. PubMed ID: 1450365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome.
    Yeung CK; Wong KL; Ng WL
    Aust N Z J Med; 1983 Aug; 13(4):349-51. PubMed ID: 6580858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse.
    Fujimoto S; Yamamoto Y; Hisanaga S; Morita S; Eto T; Tanaka K
    Am J Kidney Dis; 1991 Jun; 17(6):687-92. PubMed ID: 2042651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of nephrotic syndrome in childhood.
    Melvin T; Bennett W
    Drugs; 1991 Jul; 42(1):30-51. PubMed ID: 1718684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R; de Jong M; Monnens L
    Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.
    Imbasciati E; Gusmano R; Edefonti A; Zucchelli P; Pozzi C; Grassi C; Della Volpe M; Perfumo F; Petrone P; Picca M
    Br Med J (Clin Res Ed); 1985 Nov; 291(6505):1305-8. PubMed ID: 3933645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of the nephrotic syndrome in children].
    Linneweh F
    Minerva Med; 1973 Oct; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the effectiveness of bolus doses of prednisolone in steroid-resistant and steroid-dependent nephrotic syndrome in children].
    Kryński J; Wyszyńska T
    Pediatr Pol; 1985 Feb; 60(2):163-8. PubMed ID: 3895148
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary corticosteroid-resistant nephrotic syndrome in pediatrics].
    Tuya CO; Muñoz M; Costa JA; Repetto HA
    Medicina (B Aires); 1984; 44(1):1-7. PubMed ID: 6535901
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period].
    Forese S; Tamborino G; Genova R
    Minerva Pediatr; 1977 Mar; 29(8):547-50. PubMed ID: 865435
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F; Ahmad TM; Anwar S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose methylprednisolone therapy in nephrotic syndrome.
    Mocan H; Erduran E; Karagüzel G
    Indian J Pediatr; 1999; 66(2):171-4. PubMed ID: 10798055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.